Molecular Medicine Reports

The latest Impact Factor for Molecular Medicine Reports, according to Journal Citation Reports 2021 (Clarivate), is 3.423 (cf. 2.952 last year; this journal has an IF >3 for this first time in its existence).

The overall trend in Impact Factors for Spandidos Publications Journals featured in JCR over the course of the last 11 years is shown in the attached graphic.

The new Impact Factors for the Spandidos Publications journals that are indexed in JCR are shown in tabulated form in the attached graphic.

Following the release of Journal Citation Reports 2022 (published by Clarivate), we are pleased to announce some significant increases in the Impact Factors (IFs) for our Journals. All listed Journals have seen their IFs increase. More information to come in the following thread!

We are pleased to announce that all of our journals have increased in terms of their scores and rankings following the recent release of 'Citescore 2021'. Here is a summary all the updated information at a glance in a graphic:

Molecular Medicine Reports: latest CiteScore, 5.9; in Quartile Q2 [cf. 4.5, Q2 in 2020].

We are pleased to announce that all of our journals have increased in terms of their scores and rankings following the recent release of 'Citescore 2021'. Specific details on each of the journals are to follow:

The latest Impact Factor for Molecular Medicine Reports, according to Journal Citation Reports 2021 (Clarivate), is 2.952 (cf. 2.100 last year; an increase of 41%).

The overall trend in Impact Factors for Spandidos Publications Journals featured in JCR over the course of the last decade is shown in the attached graphic.

The new Impact Factors for the Spandidos Publications journals that are indexed in JCR are shown in tabulated form in the attached graphic.

Following the release of Journal Citation Reports 2021 (published by Clarivate), we are pleased to announce some significant increases in the Impact Factors for several of our Journals. More information to come in the following thread.

We would like to thank all our authors, reviewers, Editorial Boards and Academies, and office staff in Athens and London for their contributions to these achievements.

Molecular Medicine Reports has climbed into the second quartile (Q2) in Citescore 2020: Specific data for Molecular Medicine Reports: latest CiteScore, 4.5; Percentile, 58% (143/340); in Quartile Q2 [cf. 3.6, 47% (175/331), Q3 in 2019].

We are pleased to announce that the majority of our journals have increased in terms of their scores and rankings following the recent release of 'Citescore 2020'. Specific details on each of the journals are to follow:

The 2019 Journal Citations Reports®Impact Factor for Molecular Medicine Reports is 2.100 (up from 1.851; according to the new ranking by citations received for the Medicine, Research & Experimental category, #12/138, cf. #13/136 in 2018).

We would like to thank all our authors, reviewers, Editorial Boards and Academies, and office staff in Athens and London for their contributions to these achievements.

Please visit our website to browse recently published articles, learn about our services for English Language Editing, Formatting and Figure Preparation, and to submit your next manuscript. We would like to thank you for your continued support.

The latest cite score for Molecular Medicine Reports is 3.6, placing it at 47% (Third quartile); 175/331 in the Oncology category.

The Scopus data were released this week, and we were delighted to see all our journals increase their impact (cite scores). In particular, @IjOncology (81%; 62/331 Oncology), @OncologyReports and @BiomedicalRepo1 are in the first quartiles in their respective categories.

Based on the same database, Spandidos Publications are ranked 13th in terms of the average number of citations per article in 2014-2016 (out of the top 30 publishers in the world by volume).